SC has set deadlines for families of COVID victims to file pro bono claims, Center says


“An external period of sixty (60) days will be applicable from March 24, 2022 to file claims for compensation with the government in the event of death due to COVID-19 before March 20, 2022,” said the Ministry of Health. Union Health in a statement released on Monday.

In Order dated March 24, 2022, setting time limits for recipients to file claims for payment of ex gratia assistance to families of those who have died of COVID-19, as announced by the National Disaster Management Authority , the Supreme Court had said that for any future death, ninety days will be granted from the date of death due to COVID-19 to file the compensation claim, the Ministry of Health statement said. Health.

The earlier order to process claims and make the actual payment of compensation within thirty days from the date of receipt of the claim will continue to be enforced, the central government said.

However, the Supreme Court had ordered that in cases of extreme hardship where a plaintiff could not make a claim within the prescribed time, it would be open to the plaintiff to approach the Grievance Redress Committee and make the claim through the through the Grievance Redress Committee which will be reviewed by the Grievance Redress Committee on a case-by-case basis and if it is found by the Grievance Redress Committee that a particular claimant was unable to make the claim within the stipulated deadline which was beyond his control, his case can be considered on the merits, the health ministry statement read.

In addition, SC also ordered that, in an effort to minimize the risk of false claims, a random review of 5% of claim requests be conducted in the first instance. If someone is found to have made a false claim, it will be considered under section 52 of the Disaster Management Act 2005 and liable to be punished accordingly, said the Ministry of Health.

Also read: COVID-19: Epygen Biotech Receives Government Funding for New Affordable Vaccine


Comments are closed.